Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
08/2005
08/24/2005EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
08/24/2005EP1565433A2 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659130A Induction of apoptosis in cancer cells
08/24/2005CN1216039C Fluorinated dihydric alcohol
08/23/2005US6933352 Amphiphilic compounds having a dendritic branch structure
08/23/2005US6933319 Resorcinol derivatives
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/17/2005EP1562998A2 Novel phase change solvents
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1215073C Fungicides
08/16/2005US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products
08/16/2005US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide
08/16/2005US6929685 Alkylamine derivatives as antifouling agents
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050175682 Polyethyleneglycol-modified lipid compounds and uses thereof
08/11/2005US20050175543 Agents for magnetic imaging method
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1560599A1 Prodrugs built as multiple self-elimination-release spacers
08/10/2005CN1653142A Coating composition comprising an acetal-functional binder
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653034A 4-alkyl-2-haloaniline derivative and process for producing the same
08/10/2005CN1653025A NK1 antagonists
08/09/2005US6927290 Production of mixed acid anhydride and amide compound
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927036 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable
08/04/2005WO2005070876A1 METHOD OF ENANTHIO-SELECTIVE NUCLEOPHILIC ADDITION REACTION FOR CONVERSION OF ENAMIDE TO IMINE AND METHOD OF SYNTHESIZING α-AMINO-Ϝ-KETO ACID ESTER
08/04/2005WO2005070875A1 Process for production of amines
08/04/2005WO2005037206A3 Anti-cancer compounds and methods of use thereof
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171197 (a) asymmetrically reducing bromoacetophenone compound to a chiral phenyl-bromoethanol; (b) displacing the bromo group by primary amine to produce protected chiral phenylethanolamine, and (c) removing protecting groups to convert it to chiral phenylethanolamine; beta -adrenergic receptor agonist; asthma
08/04/2005US20050171148 Aryl and heteroaryl compounds, compositions, methods of use
08/04/2005US20050171082 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
08/03/2005EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use
08/03/2005EP1558591A2 Modulation of anxiety through blockade of anandamide hydrolysis
08/03/2005EP1309535A4 A PROCESS FOR THE PREPARATION OF $g(a)' CHLOROKETONES
08/03/2005CN1649905A Incorporable photoinitiator
08/03/2005CN1649834A Novel propionic acid derivative
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors
08/02/2005US6924396 α-haloenamine reagents
08/02/2005US6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
08/02/2005US6924307 Metalloproteinase inhibitor; antiarthritic agents, osteoporosis; cardiovascular disorders; antitumor agents; autoimmune diseases
08/02/2005US6924275 Aminophenol derivatives and their use in cosmetics
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005US20050165069 Statine derivatives for the treatment of Alzheimer's disease
07/28/2005US20050165002 Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type
07/28/2005DE10361140A1 Verfahren zur Herstellung von dendritischen Trimesinsäuretriamiden A process for the preparation of dendritic Trimesinsäuretriamiden
07/27/2005EP1556454A1 Compounds having a secondary or tertiary hydroxy or halide group separated from a primary carbamate group by three or more carbon atoms and a method of making the same
07/27/2005EP1556436A1 Polyamine derivatives, a process to make them, and their use
07/27/2005EP1556338A1 A METHOD OF PRODUCTION OF (-)-(S)-3- 1-(DIMETHYLAMINO)ETHYL& rsqb;PHENYL-N-ETHYL-N-METHYLCARBAMATE
07/27/2005CN1646484A Lactic acid derivative
07/21/2005WO2005066224A1 Water-and oil-repellent fluoroacrylates
07/21/2005WO2005066197A2 Inhibitors of methionine aminopeptidase-2 and uses thereof
07/21/2005WO2005066146A1 Method for the production of a thiazolo[3,4,5-de][4,1]benzothiazepine-type product
07/21/2005WO2004050609A8 Substituted ureas and carbamates
07/21/2005US20050159469 HIV protease inhibiting compounds
07/21/2005US20050159459 inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful to reduce forming beta peptides
07/21/2005CA2551874A1 Water-and oil-repellent fluoroacrylates
07/21/2005CA2550873A1 Inhibitors of methionine aminopeptidase-2 and uses thereof
07/20/2005EP1554263A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
07/20/2005EP1554237A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
07/20/2005EP1284959B1 Compounds for modulating the rage receptor
07/20/2005CN1642906A Novel arylamidine derivative or salt thereof
07/20/2005CN1211359C New phenalkyoxy-phenyl derivatives
07/20/2005CN1211357C Continuous process for synthesis of aromatic urethanes
07/19/2005US6919476 Simple and efficient preparation of an amino acid, alpha-tertiary-butoxycarbonylaminoethylamino-),alpha-(alkyl-)acetic acid; used to prepare peptide nucleic acids (PNA) including those having photosensitive functional groups
07/19/2005US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
07/14/2005WO2005063698A1 Process for preparing carbamates
07/14/2005WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them
07/14/2005WO2005062811A2 Catalytic sulfoxide-promoted c-h oxidation, and regioselective preparation of allylic carboxylates
07/14/2005US20050154062 Substituted chiral allosteric hemoglobin modifiers
07/14/2005US20050154057 Crystalline form of y-aminobutyric acid analog
07/13/2005EP1343754B1 Cyclophilin-binding ligands
07/13/2005EP1161415B1 N-cyanomethylamides as protease inhibitors
07/13/2005EP1144364B1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/13/2005CN1636983A Substituted heterocyclic compounds
07/12/2005US6916949 Methods of chemical systhesis of phenolic nitrogen mustard prodrugs
07/07/2005WO2005061487A1 Hiv protease inhibiting compounds
07/07/2005WO2005061446A2 Processes for the preparation of aminoalkyl phenylcarbamates
07/07/2005WO2005061445A1 Methods for carbon isotope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
07/07/2005WO2005061443A2 Benzoyl-substituted phenylalanine amides
07/07/2005WO2005061434A1 Method for producing dendritic trimesic acid triamides
07/07/2005WO2005061433A2 Aminoalcohol derivatives
07/07/2005WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/07/2005US20050148795 High yield and purity production of protease inhibitor intermediates; lower temperature; eliminates epoxide step, material handling losses and dust explosion issues
07/07/2005US20050148549 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
07/07/2005CA2548442A1 Benzoyl-substituted phenylalanine amides
07/06/2005CN1634878A Propargyl butylamino formate and its synthesis process
07/06/2005CN1634859A Symmetrel derivatives and synthesis method thereof and their use as neuron damage protective agent
07/06/2005CN1209346C Production of carbaminate by amine reacted with dimethyl ester carbonate
07/05/2005US6914157 No condensation of gas mixture occurs during compression, partially condensing compressed mixture to form gas/liquid mixture, absorbing to form an ammonium carbamate solution; reduced water content allows direct processing to urea
07/05/2005US6914096 Method of making a curable coating composition containing a carbamate functional reactive additive
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 157